English | Arabic | German | Home
Khalid Abu Ajaj Publications Publications Poster à Main menu		Publications > Poster 12. Khalid Abu Ajaj, Cynthia Schaefer-Obodozie, Norbert Esser, Felix Kratz ‘‘Development of macromolecular prodrugs with proteasome inhibitors’’ 8th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice Valencia, Spain, May 24–26, 2010 11. Bakheet Elsadek, Ralph Graeser, Norbert Esser, Khalid Abu Ajaj, Tahia Saleem, Nagla El Melegy, Hafez Madkor, Felix Kratz ‘‘Development of a novel water-soluble prodrug of paclitaxel that is cleaved by prostate-specific antigen (PSA): In vitro and in vivo evaluation’’ AACR Annual Meeting 2010 Washington DC, USA, April 17–21, 2010 10. Khalid Abu Ajaj, Ralph Graeser, Felix Kratz ‘‘Development of a dual-acting prodrug with doxorubicin and the P-glycoprotein inhibitor ONT-093 for circumventing multidrug resistance’’ AACR Annual Meeting 2009 Denver, Colorado, USA, April 18–22, 2009 9. Khalid Abu Ajaj, Felix Kratz ‘‘Development of prodrugs for combination chemotherapy’’ AACR Annual Meeting 2009 Denver, Colorado, USA, April 18–22, 2009 8. Khalid Abu Ajaj, Ralph Graeser, Iduna Fichtner, Felix Kratz "In vitro and in vivo study of an albumin-binding prodrug of doxorubicin that is cleaved by cathepsin B" AACR Annual Meeting 2009 Denver, Colorado, USA, April 18–22, 2009 7. Felix Kratz, Claudia Ryppa, Khalid Abu Ajaj ‘‘Development of ligand-based and dual acting prodrugs as the next generation of albumin-binding prodrugs’’ 7th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice Valencia, Spain, May 26–28, 2008 6. Khalid Abu Ajaj, Ralph Graeser, Christoph Schaechtele, Felix Kratz ‘‘Development of prodrugs for combination chemotherapy’’ AACR Annual Meeting 2008 San Diego, CA, USA, April 12–16, 2008 5. Gisa. Gerold, Hans-Jürgen Laws, Khalid Abu Ajaj, Michael Bienert, Arturo Zychlinsky, Juana L. de Diego ‘‘Toll-like receptor 2 dependent pattern recognition requires vitronectin and beta3 integrin’’ Keystone Symposium: Innate Immunity: Signaling Mechanisms Keystone, Colorado, USA, February 24–29, 2008 4. Khalid Abu Ajaj, Felix Kratz ‘‘Development of new albumin-binding dual acting prodrugs to overcome P-glycoprotein-mediated multidrug resistance’’ AACR Annual Meeting 2007 Los Angeles, CA, USA, April 14–18, 2007 3. Gisa Gerold, Juana de Diego, Khalid Abu Ajaj, Michael Bienert, Arturo Zychlinsky ‘‘An acute phase serum protein negatively regulates the interaction of bacterial lipoprotein with toll-like receptor 2’’ Keystone Symposium: Innate Immunity to Pathogens Steamboat Springs, Colorado, USA, January 08–13, 2005 2. Juana de Diego, Khalid Abu Ajaj, Gisa Gerold, Micael Bienert, Arturo Zychlinsky ‘‘An acute phase serum protein negatively regulates the interaction of bacterial lipoprotein with toll-like receptor 2’’ EURESCO conferences: Spatial and Temporal Dynamics of the Endomembrane System San Feliu de Guixols, Spain, October 16–21, 2004 1. Khalid Abu Ajaj, Yang Guangbin, Svetlana Zakharova, Peter Welzel ‘‘Synthesis of phosphonate analogues of moenomycin A12’’ Biology of bacterial natural substance producers Workshop, Berlin, Germany Technical University, Berlin, Germany, November 15–17, 2001

terms and conditions | اتفاقية استخدام الموقع | rechtlicher Hinweis

AbuAjaj.com© 2001-2010

last change 12.05.2010